RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 16, 16:00
RVL Pharmaceuticals Free Cash Flow (Quarterly): -13.11M for June 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2023 | -13.11M |
March 31, 2023 | -7.122M |
December 31, 2022 | -17.13M |
September 30, 2022 | -10.12M |
June 30, 2022 | 1.996M |
March 31, 2022 | -13.30M |
December 31, 2021 | -24.52M |
September 30, 2021 | -16.19M |
June 30, 2021 | -3.898M |
March 31, 2021 | -11.91M |
December 31, 2020 | -8.964M |
Date | Value |
---|---|
September 30, 2020 | 8.848M |
June 30, 2020 | 15.59M |
March 31, 2020 | -1.014M |
December 31, 2019 | -0.286M |
September 30, 2019 | 36.07M |
June 30, 2019 | 0.512M |
March 31, 2019 | -6.762M |
December 31, 2018 | 29.24M |
September 30, 2018 | 6.411M |
June 30, 2018 | -7.90M |
March 31, 2018 | 5.665M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-24.52M
Minimum
Dec 2021
36.07M
Maximum
Sep 2019
-3.798M
Average
-7.122M
Median
Mar 2023
Free Cash Flow (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -1.574M |
Palatin Technologies Inc | -8.607M |
iBio Inc | -4.706M |
Theriva Biologics Inc | -4.881M |
Oragenics Inc | -1.102M |